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Abstract
Objective: To confirm previous evidence suggesting an 
association between autism and low vitamin D serum levels.
Methods: This preliminary exploratory study assessed the 
circulating levels of 25-hydroxyvitamin D (25-OHD) in pediatric 
patients with autism and in typically developing controls from 
Juiz de Fora, Brazil.
Results: Serum levels of 25-OHD were lower in children with 
autism (26.48 ± 3.48 ng mL-1) when compared to typically 
developing subjects (40.52 ± 3.13 ng mL-1) (p < 0.001).
Conclusion: Our findings attest to the importance of vitamin 
supplementation during pregnancy and in the treatment 
of children with autism, who tend to present low vitamin D 
consumption rates.
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Resumo
Objetivo: Confirmar evidências prévias indicando uma associa-
ção entre autismo e baixos níveis séricos de vitamina D.
Métodos: Este estudo preliminar avaliou os níveis circulantes de 
25-hidroxivitamina D (25-OHD) em pacientes pediátricos com 
autismo e em controles apresentando desenvolvimento típico em 
Juiz de Fora, Brasil.
Resultados: Os níveis séricos de 25-OHD foram menores em 
crianças com autismo (26,48 ± 3,48 ng mL-1) em comparação 
com indivíduos com desenvolvimento típico (40,52 ± 3,13 ng 
mL-1) (p < 0,001).
Conclusão: Nossos resultados confirmam a importância da su-
plementação de vitamina durante a gravidez e no tratamento 
de crianças com autismo, que costumam apresentar um baixo 
consumo de vitamina D.
Descritores: Autismo, crianças, vitamina D.
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Introduction
Autism is described as a complex neurological 
condition that undermines normal brain development, 
leading to conditions such as disturbances in social 
interaction and communication impairments.1 Autism 
spectrum disorders (ASDs) are considered to be caused 
by different triggers, including nutritional ones.2
In this context, the association between autism 
and vitamin D levels has been investigated, pointing 
to possible links between deficient levels of calcitriol 
[1,25(OH)2D3] and some clinical observations3,4 – although 
no single factor can explain why more children are being 
identified with ASDs. This assumption has been made 
because this active metabolite plays several important 
roles: i) inhibition of the synthesis of inducible nitric 
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oxide synthase (iNOS), an enzyme responsible for the 
generation of nitric oxide (NO); ii) modulation of helper T 
cells, leading to a suppression of autoimmune responses5; 
iii) increase of glutathione levels; and iv) activation of the 
tyrosine hydroxylase gene expression, increasing the 
levels of neurotransmitters.6 Thus, calcitriol deficiency in 
early childhood could be in some manner associated with 
the neurological clinical aspects of autism, and therefore 
with an increased risk for developing the disorder.7
Another suggestion of the importance of vitamin D in 
the etiology of autism comes from the fact that populations 
born in environments exposed to reduced levels of UVB 
radiation, i.e., where vitamin D deficiency is more likely 
to occur, have higher prevalence rates of this disorder.7
Within this context, the present study aimed to 
conduct a preliminary investigation of the circulating 
levels of 25-hydroxyvitamin D (25-OHD) in pediatric 
patients with autism and in typically developing controls 
from Juiz de Fora, Brazil.
Methods
The study protocol followed the ethical guidelines 
contained in the Declaration of Helsinki and was 
approved by the Ethics Committee of Universidade 
Federal de Juiz de Fora, southeastern Brazil (protocol no. 
140/2007). Written informed consent was obtained from 
the participants’ legal guardians. 
The sample included 24 children (18 male and 
6 female, mean age = 7.4 ± 2.7 years) diagnosed 
with autistic disorder according to the Diagnostic and 
Statistical Manual of Mental Disorders, 4th edition (DSM-
IV), and also 24 age- and sex-matched healthy controls 
(18 male and 6 female, average age = 7.2 ± 1.8 years).8
Blood samples were collected between 7 and 9 a.m., 
after an 8-hour fast. Samples were centrifuged at 2465 x 
g for 10 minutes at 4º C, and frozen at -80º C for further 
analysis by high-performance liquid chromatography 
(HPLC), in duplicate, according to Turpeinen et al.9
For statistical analysis, independent samples t tests 
were used to determine numeric group differences. The 
chi-square test was used to assess binomial data such 
as sex. Statistical analyses were performed using the 
Statistical Package for the Social Sciences (SPSS) version 
14.0 (SPSS Inc., Chicago, IL). Two-tailed probabilities of 
p < 0.05 were considered significant. 
Results
Among our 24 children with autism, ethnic origin 
was as follows: males, nine Caucasians and nine non-
Caucasians; females, four Caucasians and two non-
Caucasians. Among controls, the following numbers were 
found: males, 15 Caucasians and three non-Caucasians; 
females, four Caucasians and two non-Caucasians.
With respect to 25-OHD levels according to the sex, 
no significant differences were observed among children 
with autism (p = 0.293) and among controls (p = 0.439). 
Conversely, serum levels of 25-OHD were significantly 
lower in children with autism (26.48 ± 3.48 ng mL-1) 
when compared with typically developing subjects 
(40.52 ± 3.13 ng mL-1) (p < 0.001). Ethnic differences 
were not taken into consideration in these analyses.
Discussion
Our results corroborate the previous study by Meguid 
et al.,4 who found 28.5 ± 16.4 ng mL-1 and 40.1 ± 11.8 
ng mL-1 of 25-OHD in children with autism and typically 
developing subjects, respectively (p < 0.001).
The 25-OHD serum levels found in our sample 
confirm that children with autism present insufficiency 
for this vitamin, according to the classification proposed 
by Holick10: deficiency, levels < 20 ng mL-1; insufficiency, 
levels between 20 and 29 ng mL-1; and normal, levels > 
30 ng mL-1. Thus, our findings underscore the presence 
of differences in 25-OHD levels between autistic and 
typically developing children.
In this light, it is possible to suggest that vitamin D 
indeed plays a role in normal brain development. Thus, 
the present findings are useful for clinicians in the sense 
of calling their attention to the possible need for dietary 
supplementation with vitamin D during pregnancy and 
also in the treatment of children with autism and low 
vitamin D consumption. Notwithstanding, we know that 
this solely, or any other isolated factor, will not reverse 
their multifactorial condition. 
Further studies are needed in order to confirm 
the prophylactic potential of vitamin D against ASDs, 
especially in view of our small sample size. We also 
suggest the performance of additional assays in the 
same population, namely serum calcium, parathyroid 
hormone, phosphate, and bone mineral density.
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